Mathias Vormehr - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Mathias Vormehr

Showing results (31-40 of 34) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 34 results.

Nature|May 27, 2021

BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humansUgur Sahin, Alexander Muik, Isabel Vogler, et al.

Nature|July 16, 2025

Author Correction: BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humansUğur Şahin, Alexander Muik, Isabel Vogler, et al.

Nature Medicine|January 6, 2025

Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trialJuanita Lopez, Thomas Powles, Fadi Braiteh, et al.

Nature|February 1, 2021

BNT162b vaccines protect rhesus macaques from SARS-CoV-2Annette B Vogel, Isis Kanevsky, Ye Che, et al.

Pageof 4

Search research articles

Showing results (31-40 of 34) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 34 results.

Nature|May 27, 2021

BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humansUgur Sahin, Alexander Muik, Isabel Vogler, et al.

Nature|July 16, 2025

Author Correction: BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humansUğur Şahin, Alexander Muik, Isabel Vogler, et al.

Nature Medicine|January 6, 2025

Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trialJuanita Lopez, Thomas Powles, Fadi Braiteh, et al.

Nature|February 1, 2021

BNT162b vaccines protect rhesus macaques from SARS-CoV-2Annette B Vogel, Isis Kanevsky, Ye Che, et al.

Pageof 4